← Leaderboards
Shuangge Ma
Yale University
$12,574,914
Attributed
$14,024,167
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,024,167 · 20
By mechanism
R01$5,606,516 · 3
P50$3,667,269 · 5
P30$2,266,698 · 2
R21$1,466,456 · 4
R03$1,017,228 · 6
Top collaborators
- Yawei Zhang3 shared
- Bao-Zhu Yang2 shared
- Charles S Dela Cruz1 shared
- Shelli Farhadian1 shared
- Tamas L Horvath1 shared
- Akiko Iwasaki1 shared
- Aaron Michael Ring1 shared
- David Van Dijk1 shared
Most similar at Yale University
Same institution · by research overlap
- R. Todd Constable$27,324,295
- Kei-Hoi Cheung$4,119,749
- Steven H. Kleinstein$20,739,430
- Keith Joiner$6,178,698
- Gordon Murray Shepherd$10,571,621
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProgramsPlayComputer SoftwareBioinformaticsData AnalysesResearch PersonnelTrainingResearch DesignClinical TrialsLeadCostFundingMalignant Neoplasm Of LungBiometrySciencePublishingInnovationGeneticBiostatistics Shared ResourceMelanomaAnticancer ResearchBaseDesign
Grant awards (59)
Core B: Biostatistics and Bioinformatics Core$259,254
P50 · FY2025 · CA · contact PI
Core C: Biostatistics and Bioinformatics Core$234,431
P50 · FY2025 · CA · contact PI
HIV Complex Causal Modeling: Gut Microbiome, Drug Use, and Immune Responses$163,625
R21 · FY2025 · DA
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis$377,922
R01 · FY2024 · CA · contact PI
Biostatistics Shared Resource$313,198
P30 · FY2024 · CA · contact PI
Core B: Biostatistics and Bioinformatics Core$232,961
P50 · FY2024 · CA · contact PI
Core C: Biostatistics and Bioinformatics Core$223,205
P50 · FY2024 · CA · contact PI
HIV Complex Causal Modeling: Gut Microbiome, Drug Use, and Immune Responses$196,350
R21 · FY2024 · DA
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis$389,856
R01 · FY2023 · CA · contact PI
Core B: Biostatistics and Bioinformatics Core$237,751
P50 · FY2023 · CA · contact PI
Core C: Biostatistics and Bioinformatics Core$206,456
P50 · FY2023 · CA · contact PI
Cancer Emulation Analysis with Deep Neural Network$167,500
R03 · FY2023 · CA · contact PI
Deep Learning-based Emulation Analysis: Methodological Developments and Case Studies$125,625
R21 · FY2023 · HL · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$1,235,421
R01 · FY2022 · AI
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis$389,856
R01 · FY2022 · CA · contact PI
Biostatistics Shared Resource$382,448
P30 · FY2022 · CA · contact PI
Core 3: Biostatistics and Bioinformatics Core$294,422
P50 · FY2022 · CA · contact PI
Core B: Biostatistics and Bioinformatics Core$226,392
P50 · FY2022 · CA · contact PI
Deep Learning-based Emulation Analysis: Methodological Developments and Case Studies$125,625
R21 · FY2022 · HL · contact PI
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis$397,813
R01 · FY2021 · CA · contact PI
Biostatistics Shared Resource$382,448
P30 · FY2021 · CA · contact PI
Core 3: Biostatistics and Bioinformatics Core$315,551
P50 · FY2021 · CA · contact PI
Core B: Biostatistics and Bioinformatics Core$223,187
P50 · FY2021 · CA · contact PI
Biostatistics Shared Resource$382,448
P30 · FY2020 · CA · contact PI
Core 3: Biostatistics and Bioinformatics Core$320,459
P50 · FY2020 · CA · contact PI
Core B: Biostatistics and Bioinformatics Core$242,665
P50 · FY2020 · CA · contact PI
Integrated Cancer Modeling: A New Dimension$83,750
R03 · FY2020 · CA · contact PI
Biostatistics Shared Resource$382,448
P30 · FY2019 · CA · contact PI
Novel methods for identifying genetic interactions in cancer prognosis$371,660
R01 · FY2019 · CA · contact PI
Core 3: Biostatistics and Bioinformatics Core$315,538
P50 · FY2019 · CA · contact PI
Integrated Cancer Modeling: A New Dimension$83,750
R03 · FY2019 · CA · contact PI
Biostatistics Shared Resource$11,906
P30 · FY2019 · CA · contact PI
Novel methods for identifying genetic interactions in cancer prognosis$383,156
R01 · FY2018 · CA · contact PI
Biostatistics Shared Resource$382,448
P30 · FY2018 · CA · contact PI
Core 3: Biostatistics and Bioinformatics Core$334,997
P50 · FY2018 · CA · contact PI
Assisted Network-based Analysis of Cancer Gene Expression Studies$83,750
R03 · FY2018 · CA · contact PI
Biostatistics Shared Resource$11,906
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$11,906
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$2,858
P30 · FY2018 · CA · contact PI
Biostatistics Shared Resource$2,684
P30 · FY2018 · CA · contact PI
Novel methods for identifying genetic interactions in cancer prognosis$383,156
R01 · FY2017 · CA · contact PI
Penalization methods for identifying gene envrionment interactions and applications to melanoma and other cancer types$144,855
R21 · FY2017 · CA · contact PI
Assisted Network-based Analysis of Cancer Gene Expression Studies$83,750
R03 · FY2017 · CA · contact PI
Novel methods for identifying genetic interactions in cancer prognosis$382,775
R01 · FY2016 · CA · contact PI
Penalization methods for identifying gene envrionment interactions and applications to melanoma and other cancer types$144,855
R21 · FY2016 · CA · contact PI
Penalization methods for identifying gene envrionment interactions and applications to melanoma and other cancer types$144,855
R21 · FY2015 · CA · contact PI
Development of Integrated Analysis Methods and Applications to TCGA data$83,250
R03 · FY2015 · CA · contact PI
Robust rank-based methods and detection of GXE in cancer etiology and survival$140,509
R21 · FY2014 · CA · contact PI
Development of Integrated Analysis Methods and Applications to TCGA data$83,250
R03 · FY2014 · CA · contact PI
Novel Methods for Integrative Analysis of Cancer Genomic Data$303,152
R01 · FY2013 · CA · contact PI
Robust rank-based methods and detection of GXE in cancer etiology and survival$136,027
R21 · FY2013 · CA · contact PI
Novel Methods for Integrative Analysis of Cancer Genomic Data$322,630
R01 · FY2012 · CA · contact PI
Robust rank-based methods and detection of GXE in cancer etiology and survival$144,130
R21 · FY2012 · CA · contact PI
Novel Methods for Integrative Analysis of Cancer Genomic Data$322,732
R01 · FY2011 · CA · contact PI
Novel Methods for Integrative Analysis of Cancer Genomic Data$346,387
R01 · FY2010 · CA · contact PI
Effective clustering penalized methods for genomic biomarker selection$78,429
R03 · FY2010 · LM · contact PI
Effective clustering penalized methods for genomic biomarker selection$95,176
R03 · FY2009 · LM · contact PI
Efficient microarray meta analysis and cancer biomarker selection$79,052
R03 · FY2009 · LM · contact PI
Efficient microarray meta analysis and cancer biomarker selection$95,571
R03 · FY2008 · LM · contact PI